Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAP7 domain-containing protein 2 (MAP7D2) is a member of the MAP7 family of microtubule-associated proteins that plays a critical role in stabilizing microtubules and regulating microtubule dynamics within cells[2][3]. It binds directly to microtubules via its positively charged N-terminal region and enhances microtubule polymerization and bundling, especially in neuronal and testicular tissues[2]. MAP7D2 also interacts with kinesin-1 (Kif5b), facilitating the tethering of this motor protein to microtubules and promoting axonal transport functions[2][3]. Loss of MAP7D2 disrupts microtubule stability, alters cell motility, and increases neurite outgrowth, indicating its involvement in neuronal development. While primarily studied for its structural cell biology roles, dysregulation of MAP7 family proteins such as MAP7D2 has been linked to neurodegeneration, including roles described in Parkinson’s disease models[3]. There are currently no known therapeutic agents directly targeting MAP7D2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAP7 domain-containing protein 2 (MAP7D2).